SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Park Ha Biological Technology Co., (BYAH) — Jan 22, 2026

Park Ha Biological Technology Co., Ltd.
Date: Jan. 22, 2026 · CIK: 0001986247 · Accession: 0001213900-26-006899

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290410

Date
January 22, 2026
Author
D. Boral Capital LLC
Form
CORRESP
Company
Park Ha Biological Technology Co., Ltd.

Letter

Via EDGAR Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549

Re: Park Ha Biological Technology Co., Ltd.

Dear SEC Officers:

Registration Statement on Form F-1, as amended (File No. 333-290410)

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the " Securities Act "), D. Boral Capital LLC, as the placement agent, hereby join the Company's requests that the effectiveness of the above-referenced Registration Statement on Form F-1 (the "Registration Statement") be accelerated and that the Registration Statement become effective at 4:00 p.m., Eastern Time, on January 26, 2026, or as soon thereafter as practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act, please be advised that there will be distributed to each placement agent or dealer, who is reasonably anticipated to participate in the distribution of the securities in this offering, as many copies of the Preliminary Prospectus, dated December 5, 2025, as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

The undersigned advises that it has complied and will continue to comply, and that they have been informed by the participating dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
D. Boral Capital LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 January 22, 2026

 Via EDGAR

 Division of Corporation Finance

 Office of Industrial Applications and Services

 100 F Street, N.E.

 Washington, D.C. 20549

 Dear SEC Officers:

 Re:
 Park Ha Biological Technology Co., Ltd.

 Registration Statement on Form F-1, as amended (File No. 333-290410)

 Request for Acceleration of Effectiveness

 Ladies and Gentlemen:

 In accordance with Rule 461 of the General Rules
and Regulations under the Securities Act of 1933, as amended (the " Securities Act "), D. Boral Capital LLC, as
the placement agent, hereby join the Company's requests that the effectiveness of the above-referenced Registration Statement on
Form F-1 (the "Registration Statement") be accelerated and that the Registration Statement become effective at 4:00 p.m.,
Eastern Time, on January 26, 2026, or as soon thereafter as practicable.

 Pursuant to Rule 460 of the General Rules and
Regulations under the Securities Act, please be advised that there will be distributed to each placement agent or dealer, who is reasonably
anticipated to participate in the distribution of the securities in this offering, as many copies of the Preliminary Prospectus, dated
December 5, 2025, as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

 The undersigned advises that it has complied and
will continue to comply, and that they have been informed by the participating dealers that they have complied with and will continue
to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 Very truly yours,

 D. Boral Capital LLC

 /s/ Stephanie Hu

 Name:
 Stephanie Hu

 Title:
 Co-Head of Investment Banking

 cc:
 Mclaughlin & Stern, LLP
Concord & Sage PC